Medileo Pharma Private Limited
About Medileo Pharma Private Limited
Data last updated:
Medileo Pharma Private Limited was a private limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the chemical products segment of the chemicals sector. It was incorporated on 18 July 2016.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2016PTC095066. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Dasaradha Rao Nandam and Nandam Santhi Sri.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Bangalore, Karnataka.
As per the financials filed for FY 2018, the company reported a revenue of ₹21.9 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.41 Lakh (net margin -6.4%) and EBITDA of -₹1.1 Lakh (EBITDA margin -5%).
Company details
Contact details
Medileo Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo. 115/2 Flat No A3 S Innovtions B. Narayanapura Near Mahadeva Pura Junc, Tion, Bangalore, Karnataka, India – 560016
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Medileo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medileo Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medileo Pharma Private Limited, buy the company report.
Financials of Medileo Pharma Private Limited
FY 2018 filings availableMedileo Pharma Private Limited reported revenue of ₹21.9 Lakh (up 588% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 588% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.1 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.41 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -5% | |
| Net Profit Margin | -6.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medileo Pharma Private Limited, buy the company report.
Board of directors of Medileo Pharma Private Limited
Medileo Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dasaradha Rao Nandam | Director | 18 Jul 2016 | 10 Years 3 Months | As last reported |
| Nandam Santhi Sri | Director | 07 Dec 2018 | 7 Years 10 Months | As last reported |
Peer comparison
Medileo Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Megacure Laboratories Pvt Ltd | ₹22 Lakh (FY 2015) | 30.0% | 24 Parganas, West Bengal, India | |||
| Rohit Proteins Pvt.Ltd. | ₹22 Lakh (FY 2025) | -40.0% | Indore, Madhya Pradesh, India | |||
| Sankalp Medicare Private Limited | ₹21.98 Lakh (FY 2019) | 10.0% | Delhi, India | |||
| Verity Healthcare Private Limited | ₹21.96 Lakh (FY 2015) | 115.0% | Uttar Pradesh, India | |||
| Tritonia Pharmaceutical (OPC) Private Limited | ₹21.92 Lakh (FY 2025) | 46.0% | Chennai, Tamil Nadu, India | |||
| Medileo Pharma Private Limitedthis company | ₹21.9 Lakh (FY 2018) | -₹1.41 Lakh | -6.4% | 588.0% | Bangalore, Karnataka, India | |
| Selvi Pharmaceuticals Private Limited | ₹21.88 Lakh (FY 2024) | -20.0% | Hyderabad, Telangana, India | |||
| Shree Hemal Organics Private Limited | ₹21.86 Lakh (FY 2024) | -13.0% | Silvassa, Dadra and Nagar Haveli, India | |||
| Cementolime Sustainable Coatings Private Limited | ₹21.86 Lakh (FY 2025) | Ratan Lal Nagar, Uttar Pradesh, India | ||||
| Dazzling Plaster Private Limited | ₹21.85 Lakh (FY 2017) | -5.0% | Gwalior, Madhya Pradesh, India | |||
| Shravin Labs Private Limited | ₹21.85 Lakh (FY 2020) | -21.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Medileo Pharma Private Limited, buy the company report.
Auditor
Medileo Pharma Private Limited is audited by V. Sai Ram for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. Sai Ram | FY 2017 | 240554 |
Shareholding
The shareholding of Medileo Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medileo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medileo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medileo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medileo Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Medileo Pharma Private Limited, buy the company report.
Recent activity
Medileo Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Nandam Santhi Sri was appointed as Director on 07 Dec 2018.
Frequently asked questions
Medileo Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Medileo Pharma was a private limited company based in Bangalore, Karnataka, India. The company worked in chemical products, within the chemicals industry. It was incorporated on 18 July 2016 and is registered under CIN U24299KA2016PTC095066. The company has been struck off by the Registrar of Companies and is no longer operational.
Medileo Pharma had 2 directors:
- Dasaradha Rao Nandam - Director
- Nandam Santhi Sri - Director
The CIN (Corporate Identification Number) of Medileo Pharma is U24299KA2016PTC095066. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Medileo Pharma is at No. 1152 Flat No A3 S Innovtions B. Narayanapura Near Mahadeva Pura Junc, Tion, Bangalore, Karnataka, India – 560016.
Medileo Pharma was incorporated on 18 July 2016. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Medileo Pharma on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
No. Medileo Pharma has 1 GST registration on record and it is cancelled or inactive.
Medileo Pharma operated in the chemicals industry, in the chemical products segment. It worked in this industry before it was struck off.
The peers of Medileo Pharma by revenue are Megacure Laboratories Pvt Ltd, Rohit Proteins Pvt.Ltd, Sankalp Medicare Private Limited, Verity Healthcare Private Limited, Tritonia Pharmaceutical (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nandam Santhi Sri was appointed as Director on 07 Dec 2018. Nandam Venkata Subba Rao ceased to be Director on 10 Mar 2018. Dasaradha Rao Nandam was appointed as Director on 18 Jul 2016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
